GL1X · GenesisL1 explorer

Research workbench

Crystal structure of HCV NS3/4A protease variant R155K in complex with asunaprevir

Analyse Crystal structure of HCV NS3/4A protease variant R155K in complex with… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
4WH6
Type
protein
Length
200 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Genome polyprotein
UniProt
A8DG50
Ligands
2R9, ZN, SO4
Pockets
1 · best druggability 0.29

Structure

x-ray diffraction · 1 distinct chain · 14% helix, 44% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AGenome polyproteinprotein20014% helix, 44% strandA8DG50

Ligands and binding sites

  • 2R9 · N-(tert-butoxycarbonyl)-3-methyl-L-valyl-(4R)-4-[(7-chloro-4-methoxyisoquinolin-1-yl)oxy]-N-{(1R,2S)-1-[(cyclopropylsulfonyl)carbamoyl]-2-ethenylcyclopropyl}-L-prolinamide · ligand · chains A
  • ZN · Zinc ion · metal · chains A
  • SO4 · Sulfate ion · ion · 2 copies · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

1 pocket found on a 1 Å grid, 0 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
1530.290.7516empty

Compared structures

  • 4WH6 · Crystal structure of HCV NS3/4A protease variant R155K in complex with Asunaprevir · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.